A detailed history of Avion Wealth transactions in Alkermes Plc. stock. As of the latest transaction made, Avion Wealth holds 21 shares of ALKS stock, worth $596. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Previous 21 -0.0%
Holding current value
$596
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$23.21 - $27.24 $417 - $490
-18 Reduced 46.15%
21 $0
Q1 2024

May 03, 2024

BUY
$26.4 - $32.56 $475 - $586
18 Added 85.71%
39 $2,000
Q4 2023

Jan 26, 2024

BUY
$23.37 - $28.68 $46 - $57
2 Added 10.53%
21 $1,000
Q2 2023

Jul 14, 2023

BUY
$28.34 - $33.63 $538 - $638
19 New
19 $0

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.67B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.